[The hemoprotective effect of Dicarbamin in ovarian cancer patients receiving chemotherapy].
The effect of dicarbamin on the hemopoetic cells of the bone marrow of ovarian cancer patients receiving myelosuppressive combination chemotherapy (cyclophosphamide + carboplatin) is discussed.